Could a home air filter help your heart?

NCT ID NCT05903950

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This trial tests whether using portable HEPA air cleaners at home can reduce exposure to fine air pollution particles and, in turn, lower systolic blood pressure in people with metabolic syndrome. Participants in Qatar will use either a real HEPA filter or a sham filter for four weeks. The study measures changes in blood pressure, blood sugar, and insulin resistance to see if cleaner indoor air can improve cardiovascular health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
In-home portable air cleaners with HEPA filters
What this could lead to
If effective, using HEPA air cleaners at home could become a simple, non-drug way to lower blood pressure and improve metabolic health in polluted areas.
What could go wrong
This is a small, short-term trial, so benefits may be modest or not last. It also only includes non-smokers with mild hypertension, so results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Non-smokers (100% abstinence from use of any smoking or vaping product during the prior year) * Age ≥18 and less than 60 years old * Living in a single residence (home, apartment) located anywhere in Qatar * Mild systolic hypertension: screening visit systolic BP 130 to 159 mm Hg (off treatment or taking ≤ 2 BP medications that have been stable without changes during prior 4 weeks) plus ≥ 2 more additional criteria for the metabolic syndrome: * Waist circumference ≥102 cm if male and ≥88 cm if female * Fasting triglycerides ≥150 mg/dL (or taking a triglyceride-lowering medication) * HDL-C ≤ 40 mg/dL if male and ≤ 50 mg/dL if female (or taking an HDL-raising medication), * Fasting glucose ≥100 mg/dL Exclusion Criteria: * Pregnancy (self-reported) * Screening visit urine positive for cotinine (NicAlert \>100 ng/mL) * Living with an active smoker who smokes indoors (by self-report) * High risk conditions that prohibit allowing home BP to be \>130/80 mm Hg during the10-week trial including any cardiovascular disease (coronary artery disease, prior stroke, heart failure, peripheral arterial disease, aneurysm) or ≥ stage 3 kidney disease (estimated glomerular filtration rate \< 60 ml/min) * A medical condition placing the participant at risk from participation (per investigators) * Expected overnight travel outside their residence during the study * HEPA filter within the air conditioners of the residence (self-reported) or individual use of HEPA filter * Unable to comprehend/sign an informed consent * Lung disease requiring oxygen * Cancer receiving treatment * Screening visit: BP ≥160/100 mm Hg or fasting blood glucose ≥126 mg/dL and confirmed diabetes with follow-up HbA1c ≥6.5%. If glucose is elevated ≥126 mg/dL but HbA1c\<6.5%, they could still participate. * Medication changes in past 4 weeks. If participants are on medications for high BP or hyperlipidemia, they will need to have had stable therapy during prior 10 weeks with no planned changes during the study * Left upper arm circumference \>17 inches as this will make BP levels inaccurate with the home monitor used * Acute illness or infectious symptoms within the prior 4 weeks.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypertension, systolic are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hamad Medical Corporation

    RECRUITING

    Doha, Qatar

More trials for these conditions

Other studies related to the condition(s) this trial covers.